The value of medical innovation versus industry rewards

10 March 2023 - This article provides systematic evidence on the share of the value of health generated by drugs and ...

Read more →

Making cancer treatments affordable today won’t hurt tomorrow’s innovation

12 May 2021 - Congress is about to debate legislation—the Lower Drug Costs Now Act (H.R.3)—that would give Medicare the ...

Read more →

The case for using novel value elements when assessing COVID-19 vaccines and therapeutics

23 June 2020 - In the span of mere weeks, the novel coronavirus (COVID-19) has upended modern life. Schools and businesses ...

Read more →